Clinical Trial Summary
Sexual dysfunction consists of a disorder of the sexual response, either in terms of desire,
or in terms of vasocongestion, or in terms of orgasmic response, or in more than one phase of
this response :
Sexual dysfunctions are today described by the Diagnostic and Statistical Manual (DSM) V as:
- Disorders of sexual desire or decreased libido
- Sexual arousal disorder
- Delayed or absent orgasmic disorder
- Sexual disorder with pain Moreover, sexual dysfunctions are not without consequences on
the life of a couple. The origins of these dysfunctions are multiple, but the result is
most of the time the same: fear of failure, feeling of incompetence, anxiety,
frustration or misunderstanding.
To date, the scientific community benefits from a few self-administered questionnaires to
measure the impact of certain dysfunctions. None takes into account all the dimensions of
male sexuality. In Italy, the Brief Index of Sexual Functioning for Men is used. This
questionnaire contains 22 items, grouped into 7 areas exploring all of male sexuality:
desire, arousal, frequency of activity, receptivity, pleasure/orgasm, relationship
satisfaction, problem affecting sexuality. This questionnaire is not currently validated in
French, whereas the Brief Index of Sexual Functioning for Women is validated.
In this context, the Andrology Committee of the French Association of Urology wishes to
create a pilot study with French patients presenting sexual dysfunctions with the aim of
validating the questionnaire in French. Patient responses to each item will:
- to determine if the formulation of the items is understandable by all, or if this is not
the case
- to identify the difficulties it can cause, and their causes. Patients treated for sexual
dysfunction will be informed of the possibility of answering a questionnaire and that
their data will be recorded for the purpose of studying practices and analyzing the
results in an anonymous setting, and confidential via the delivery of the information
leaflet dedicated to the study. They will have the opportunity to signify their refusal
to participate without risk of modification of the coverage.
